Serial #79219522
LIVE

Serial Number

79219522

Owner

Tentamus Group GmbH

Attorney

Catherine F. Hoffman

Filing Date

Apr 12, 2017

Add to watchlist:

No watchlists yet
View on USPTO

Serial #79219522 Trademark

Serial Number: 79219522 • Registration: 5724198

Serial #79219522 is a trademark filed by Tentamus Group GmbH on April 12, 2017. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Tentamus Group GmbH (2 trademarks)

An der Industriebahn 5

Entity Type: 27

Trademark Details

Filing Date

April 12, 2017

Registration Date

April 16, 2019

Published for Opposition

January 29, 2019

Goods & Services

Conducting of analytical, chemical, physicochemical, physical, biochemical, biological, molecular biological, microbiological, enzymatic and sensory tests of foodstuffs, pharmaceutical products, cosmetics, commodities, foodstuffs for animals, tobacco products, beverages and drinking water to determine the composition, nutritional values or selected parameters for characterizing product quality or for testing the observance of the legally required limit values or the observance of specification values for the aforementioned products; product testing in order to check conformity of the declarations and marking of packaging; testing the declarations and marking of packaging for conformity on the packaging itself; testing the accuracy of declarations and marking of packaging by testing the product contained inside said packaging to determine if the product conforms to the declarations and markings on the packaging; conducting quality checking and safety checking on imported goods; product quality checking and testing; testing, analysis and evaluation services of quality standards in foodstuffs, foodstuffs for animals and beverages; testing ingredients and additives in foodstuffs, pharmaceutical products, cosmetics, commodities, foodstuffs for animals, tobacco products, beverages and drinking water to determine the composition, nutritional values or selected parameters for characterizing product quality or for testing the observance of the legally required limit values or the observance of specification values for the aforementioned products; testing, analysis and evaluation services of quality standards, namely, determining the composition, nutritional values or selected parameters for characterising product quality for foodstuffs, pharmaceutical products, cosmetics, commodities, foodstuffs for animals, tobacco products, beverages and drinking water, in particular of meat and charcuterie, fish and fish products, dairy products, edible fats, bread and bakery products, ices, convenience goods, foodstuffs, confectionery, foodstuffs for animals; testing, analysis and evaluation services of quality standards, namely, determining the composition, nutritional values or selected parameters for testing the observance of legally required limit values or the observance of specification values for foodstuffs, pharmaceutical products, cosmetics, commodities, foodstuffs for animals, tobacco products, beverages and drinking water, in particular of meat and charcuterie, fish and fish products, dairy products, edible fats, bread and bakery products, ices, convenience goods, foodstuffs, confectionery, foodstuffs for animals; testing, analysis and evaluation services relating to the application of standards, in particular good manufacturing practice (GMP) and global food safety initiative standards and other commercial checking standards; consultancy relating to quality control; developing, testing and implementation of quality management systems to support and aid others in controlling product quality for foodstuffs, pharmaceutical products, cosmetics, commodities, foodstuffs for animals, tobacco products, beverages and drinking water; developing, testing and implementation of quality management systems for controlling product quality of foodstuffs, pharmaceutical products, cosmetics, commodities, foodstuffs for animals, tobacco products, beverages and drinking water; design, development and implementation of quality management and self-inspection systems and HACCP (hazard analysis and critical control points) concepts to support and aid others in controlling product quality for foodstuffs, pharmaceutical products, cosmetics, commodities, foodstuffs for animals, tobacco products, beverages and drinking water; design, development and implementation of quality management and self-inspection systems and HACCP (hazard analysis and critical control points) concepts for controlling product quality of foodstuffs, pharmaceutical products, cosmetics, commodities, foodstuffs for animals, tobacco products, beverages and drinking water; testing, analyzing, procuring of samples and evaluation services for the chemical and microbiological testing of foodstuffs, foodstuffs for animals, beverages, drinking water, pharmaceutical products, cosmetics, commodities and tobacco products to determine the composition, nutritional values or selected parameters for characterizing product quality or for testing the observance of the legally required limit values or the observance of specification values for the aforementioned products

Conducting of training courses and seminars, in particular for imparting knowledge in the field of food hygiene and food legislation

[ Diagnostic preparations for medical, pharmaceutical or veterinary purposes; in-vitro diagnostic preparations for medical or veterinary use; chemical reagents for medical or veterinary purposes; reagents for in-vitro laboratory use for veterinary or medical purposes; reagents for microbiological analysis, in particular for veterinary or medical purposes; genetic and molecular-biological identity tests, in particular comprised of reagents for medical or veterinary purposes; immunoreagents for medical or veterinary purposes; chemical preparations for use in nucleic acids and medical protein analysis, in particular in DNA and RNA; preparations of microorganisms for medical or veterinary purposes; preparations for detecting genetic predispositions for medical or veterinary purposes; preparations for detecting genes for medical or veterinary purposes, in particular mutated genes; bouillons for biological cultures, in particular bacteriological cultures; nutritive substances for microorganisms; serums, in particular antiserums for diagnostic purposes; antibodies for diagnostic purposes; diagnostic biomarker reagents for medical or veterinary purposes; contrasting agents for diagnostic ultrasound imaging ]

[ Biochips for research or scientific purposes; biological microscopes; chemistry apparatus and instruments used for mechanical and functional testing of medical device technologies, namely, mass spectrometers; chemistry apparatus and instruments, namely, apparatus, instruments in the nature of inductively coupled plasma torches and atomic emission spectrometers used together for analysis and testing of medical device technologies; chemistry apparatus and instruments, namely, apparatus, instruments in the nature of liquid chromatography separating apparatus and mass spectrometers used together for analysis and testing of medical device technologies; chemistry apparatus and instruments, namely, apparatus, instruments in the nature of gas chromatography separating apparatus and mass spectrometers used together for analysis and testing of medical device technologies; chemistry apparatus and instruments, namely, apparatus and instruments in the nature of Fourier-transform infrared spectrometers, ultraviolet-visible spectrometers, nuclear magnetic resonance spectrometers and mass spectrometers for testing gas, liquids and solids; chemistry apparatus instruments, namely, apparatus and instruments in the nature of flow cytometry analyzers and sorters, real time PCR thermal cyclers, mass cytometry analyzers, and liquid handling robots for testing and analyzing chemical and biological substances for the presence, absence, or quantity of target chemicals, contaminants, pathogens, allergens, antigens, metabolites, proteins, biologics; DNA microarrays; DNA chips; filter diaphragms for laboratory use; chromatography components in the nature of injectors, columns and apparatus for laboratory use, in particular liquid chromatography injectors, columns and apparatus for laboratory use; laboratory apparatus in the nature of laboratory freezers for cryogenic preservation, pipettes, microplates, microplate readers, microplate spectrophotometers, microplate photometers, microplate washers, thermal cyclers (PCR machines), real time PCR thermal cyclers and DNA sequencers for analyzing diseases and genome information for the purposes of performing NGS (Next Generation Sequencing) tests, ELISA (Enzyme-linked Immunosorbent Assay) tests, PCR (Polymerase Chain Reaction) tests and related technologies and methods; laboratory apparatus in the nature of laboratory freezers for cryogenic preservation, pipettes, microplates, microplate readers, microplate spectrophotometers, microplate photometers, microplate washers, thermal cyclers (PCR machines), real time PCR thermal cyclers and DNA sequencers for analyzing diseases and genome information, including but not limited to apparatus for the purposes of performing NGS (Next Generation Sequencing) tests, ELISA (Enzyme-linked Immunosorbent Assay) tests, PCR (Polymerase Chain Reaction) tests; laboratory apparatus for analyzing diseases and genome information, namely, laboratory apparatus in the nature of centrifuges, homogenizers and thermal cyclers (PCR machines) for extracting nucleic acid, DNA, RNA; laboratory apparatus for analyzing diseases and genome information, namely, laboratory apparatus in the nature of DNA sequencers for sequencing nucleic acid, DNA, RNA; laboratory apparatus in the nature of thermal cyclers (PCR machines) and real time PCR thermal cyclers for sequencing nucleic acid, DNA, RNA; laboratory apparatus for analyzing diseases and genome information, namely, laboratory apparatus in the nature of thermal cyclers (PCR machines) and real time PCR thermal cyclers for detecting genetic sequences; laboratory apparatus for analyzing diseases and genome information, namely, laboratory apparatus in the nature of electropheresis systems and spectrophotometers for analyzing proteins; laboratory apparatus for analyzing diseases and genome information, namely, laboratory apparatus in the nature of mass spectrometers, spectrophotometers and real time PCR thermal cyclers for testing and analyzing chemical and biological substances for the presence, absence, or quantity of target chemicals, contaminants, pathogens, allergens, antigens, metabolites, proteins, biologics; laboratory apparatus for analyzing diseases and genome information, namely, laboratory apparatus in the nature of mass spectrometers, ultraviolet-visible spectrometers, Fourier-transform infrared spectrometers, nuclear magnetic resonance spectrometers, time-of-flight mass spectrometers, isotope ratio mass spectrometers, thermal cyclers (PCR machines), real time PCR thermal cyclers and DNA sequencers for testing foodstuffs, pharmaceutical products, cosmetics, commodities, foodstuffs for animals, tobacco products, beverages and drinking water for the presence of contaminants; apparatus for laboratories, in particular optical apparatus in the nature of video cameras and interferometers used for mechanical and functional testing of medical device technologies, namely, Prosthetic Heart Valve Testing Systems comprised of a pump, pressure sensors and laboratory tray, Endovascular Prostheses Testing Systems comprised of a pump, pressure sensors and laboratory tray, Pulsatile Pump Systems comprised of a pump, pressure sensors and laboratory tray, Heating Circulator Apparatus in the nature of an electric laboratory bath, Simulated Use Test Systems comprised of a pump, pressure sensors and laboratory tray and Silicone Mock Vessels and Anatomical Models; apparatus for laboratories, in particular optical apparatus, namely, optical inspection apparatus; apparatus for laboratories, in particular optical apparatus, namely, optical sensors, cameras, scanners, collimators, interferometers, monochromators, refractometers, spectrometers, microscopes; separating apparatus in the nature of centrifuges for laboratory use used for mechanical and functional testing of medical device technologies, namely, Prosthetic Heart Valve Testing Systems comprised of a pump, pressure sensors and laboratory tray, Endovascular Prostheses Testing Systems comprised of a pump, pressure sensors and laboratory tray, Pulsatile Pump Systems comprised of a pump, pressure sensors and laboratory tray, Heating Circulator Apparatus in the nature of an electric laboratory bath, Simulated Use Test Systems comprised of a pump, pressure sensors and laboratory tray and Silicone Mock Vessels and Anatomical Models; separating apparatus for laboratory use, namely, laboratory instruments in the nature of gas chromatography separating apparatus and liquid chromatography separating apparatus for the separation of mixtures of chemical compounds; separating apparatus for laboratory use, namely, laboratory centrifuges; chromatography separating apparatus for laboratory use; separating apparatus for laboratory use, namely, pre-packed columns for use in separation and purification ]

Business management and business administration, for others

Filing History

PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Apr 18, 2026 INPR
NEW REPRESENTATIVE AT IB RECEIVED
Nov 14, 2025 NREP
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Aug 18, 2025 NA71
REGISTERED - PARTIAL SEC 71 ACCEPTED
Aug 18, 2025 71.P
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Aug 12, 2025 APRE
TEAS SECTION 71 RECEIVED
May 21, 2025 ES71
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Apr 16, 2024 REM3
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 27, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 27, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 27, 2024 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Feb 27, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Feb 27, 2024 COAR
FINAL DECISION TRANSACTION PROCESSED BY IB
Aug 30, 2019 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Aug 8, 2019 FICS
FINAL DISPOSITION PROCESSED
Aug 8, 2019 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jul 16, 2019 FICR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 19, 2019 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 19, 2019 REAP
REGISTERED-PRINCIPAL REGISTER
Apr 16, 2019 R.PR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Apr 12, 2019 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 27, 2019 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Mar 27, 2019 OPNR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 29, 2019 NPUB
PUBLISHED FOR OPPOSITION
Jan 29, 2019 PUBO
NOTIFICATION PROCESSED BY IB
Jan 25, 2019 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 9, 2019 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jan 9, 2019 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 9, 2019 NONP
ASSIGNED TO LIE
Dec 26, 2018 ALIE
EXPARTE APPEAL TERMINATED
Dec 11, 2018 EXPT
EXPARTE APPEAL TERMINATED
Dec 8, 2018 EXPT
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 4, 2018 CNSA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 30, 2018 TCCA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Nov 30, 2018 ERFR
EX PARTE APPEAL-INSTITUTED
Nov 30, 2018 EXPI
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Nov 30, 2018 JURT
EXPARTE APPEAL RECEIVED AT TTAB
Nov 30, 2018 EXAF
NOTIFICATION OF FINAL REFUSAL EMAILED
May 31, 2018 GNFN
FINAL REFUSAL E-MAILED
May 31, 2018 GNFR
FINAL REFUSAL WRITTEN
May 31, 2018 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
May 14, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 14, 2018 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 14, 2018 TROA
ATTORNEY REVIEW COMPLETED
May 9, 2018 ATRV
LIMITATION FROM THE IB - REQUEST EXAM REVIEW
May 9, 2018 LIME
LIMITATION OF GOODS RECEIVED FROM IB
Apr 5, 2018 LIMG
REFUSAL PROCESSED BY IB
Dec 1, 2017 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 13, 2017 RFCS
REFUSAL PROCESSED BY MPU
Nov 13, 2017 RFRR
APPLICATION FILING RECEIPT MAILED
Nov 3, 2017 MAFR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 2, 2017 RFCR
NON-FINAL ACTION WRITTEN
Nov 1, 2017 CNRT
ASSIGNED TO EXAMINER
Oct 30, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 30, 2017 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Oct 26, 2017 REPR